Author's posts
HHS shifts organ transplant network to multi-vendor model: 6 notes
The Health Resources and Services Administration has awarded new contracts to multiple vendors for the nation’s organ transplant system, ending decades of reliance on the United Network for Organ Sharing as its sole contractor.
California hospital names acting CEO
Carly Loper has been named acting CEO of Brawley, Calif.-based Pioneers Memorial Healthcare District following the departure of Christopher Bjornberg.
13 drugs expected to be included in CMS negotiations: Study
CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.
2 hospitals abruptly close
Over the last 10 days, one acute-care hospital in Alabama suspended operations indefinitely, with another physician-owned hospital in California following suit.
Smiths Medical recalls ventilators after reported death
Smiths Medical is recalling its paraPAC Plus ventilators because of the possibility that the patient outlet connector could loosen or detach, affecting active ventilation.
AdventHealth CEO's 5 tips to navigate resistance
Pushing through resistance is vital in creating change for the future, according to Terry Shaw, president and CEO of Altamonte Springs, Fla.-based AdventHealth.
How a community flash point sparked a $30M Allina Health investment
Amid civil unrest in 2020, spurred by various social, political and economic factors, Allina Health had its own moment of reflection. The Minneapolis-based health system, whose corporate headquarters and flagship hospital are blocks from where George F…
$180M bond deal to fund WoodBridge's acquisition of Pennsylvania system
Nonprofit organization WoodBridge Healthcare intends to use bond financing debt to acquire a three-hospital system in Pennsylvania from Community Health Systems, The Scranton Times-Tribune reported Sept. 23.
Federal court revives hundreds of lawsuits over osteoporosis drug
A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, which plaintiffs allege increases risk of thigh bone fractures, according to court documents reviewed by Becker’s.
Inside the GLP-1 'price war'
GLP-1 manufacturers are now offering significant discounts to entice payers and employers to cover their popular medications, The Wall Street Journal reported Sept. 20.
